NewTouch Digital

NewTouch Digital, founded in Washington D.C., is a health technology company focused on optimizing clinical care for neurodegenerative diseases through its mobile health and data analytics platform. The company aims to digitally reshape and improve care models by integrating its technology with doctors, patients, and industry partners. Their flagship product, NeuroRPM-Rx, is an FDA-cleared, physician-prescribed application for managing Parkinson's disease using advanced AI on the Apple Watch to monitor key symptoms and manage medications.

Notable affiliated individuals include leading neurologists and data scientists who contribute to the development and clinical trials of their technology. The company has garnered attention from prominent investors in the health tech space, supporting its mission to enhance patient outcomes. Key achievements include successful clinical trials and FDA clearance for NeuroRPM-Rx, positioning NewTouch Digital as a significant player in the digital health landscape. Their impact is seen in improved disease management and patient care for those suffering from neurodegenerative conditions.